Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Equipment >

Ekso Bionics Holdings, Inc. (EKSO)

Add EKSO Price Alert      Hide Sticky   Hide Intro
Moderator: mick, skepticone, Rhetorical
Search This Board: 
Last Post: 6/22/2017 6:50:27 PM - Followers: 83 - Board type: Free - Posts Today: 8

Industry leaders in healthcare, military, and industrial exoskeletons 
                                         (Continue below to message board)                                  


Ekso GT (Healthcare):

Ekso GT is a robotic exoskeleton used for over-ground gait training in people with a neurological diagnosis. It helps patients re-learn the correct step patterns and weight shifts involved in walking, potentially mitigating compensatory behaviors.

Ekso GT’s Variable Assist software allows physical therapists to determine how much power is provided to either side of the person’s body. This balances the physical effort that the person exerts with the amount of help that he or she needs to achieve a more normalized gait. It also makes the device suitable for a broad spectrum of neuro-rehabilitation activities and keeps individuals challenged as they progress through their rehabilitation.

For people who thought they would never stand or walk again, Ekso GT provides hope for greater mobility and independence.

[Christina Kwasnica, M.D., medical director for the Barrow Neuro Rehabilitation Center, notes, “The robotic device allows us to get patients up on their feet earlier. The gains we see are overwhelming and the positive effects on a patient’s mood and motivation is unbelievable.”]

Ekso Bionics(TM) Receives Its First NIH Grant (Oct 28, 2014):
RICHMOND, Calif., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that it has been awarded a P20 Exploratory Grant from the National Institutes of Health (NIH) to continue the development of an exoskeleton prototype for children. This work will be done in collaboration with the pediatric rehabilitation department at the UCSF Benioff Children's Hospital Oakland and will consist of Ekso Bionics developing a pediatric version of its Ekso GT™ robotic exoskeleton. Working with UCSF Benioff Children's Hospital Oakland allows for the effective integration of advanced robotics into a world-class pediatric rehabilitative practice.

Ekso Bionics Licences Intellectual Property to Ottobock: (Nov 3, 2014):

Ekso: T.A.L.O.S. & Warrior Web (D.O.D.):

T.A.L.O.S. (Tactical Assault LIght Operator Suit):
Ekso Labs was awarded an Other Transaction for Prototypes Agreement from U.S. Special Operations Command (SOCOM) to develop technologies for their Tactical Assault Light Operator Suit (TALOS) project. TALOS is a futuristic assault suit that promises to provide superhuman strength with superior mobility and protection, and is often referred to as the "Iron Man" suit. The exoskeleton chassis, which Ekso Labs is developing, will be designed to allow soldiers to carry out their mission with agility, while carrying hundreds of pounds of load. The TALOS project is integrating other functional elements, including armor and systems, to provide situational awareness and technology for vital signs monitoring.

Ekso Bionics(TM) Secures Second Phase of U.S. Special Operation Command's TALOS Project

Ekso(TM) Labs Secures Third Contract With the U.S. Special Operations Command (SOCOM) for Upper Extremity TALOS Project (5/20/15)

Warrior Web Flexible Exoskeleton:
Ekso Bionics™ Selected for Development of Next-Generation DARPA Exoskeleton

Warrior Web A:
Testing for the Warrior Web Task A project culminated last week with six soldiers marching through 84 miles of obstacle filled terrain, carrying large loads, weapon and helmet. There were no incidences of failure reported.

Warrior Web B:

"Ekso Bionics (NASDAQ: EKSO), having successfully supplied technology to Warrior Web Task A, has been selected to participate in the second and concluding Warrior Web Task B.

Ekso Bionics will gain $4.5 million in the combined contract for both tasks." - RBR

Army R&D with RE2 Robotics:
(This is from a press release from RE2, not from Ekso Bionics. Ekso is simply jointly involved as mentioned below)
Note: EKSO is now on the NASDAQ exchange not the OTCBB

"The goal of the Phase II effort is to develop a simulation tool capable of producing validated biomechanical data on muscle forces, stresses, joint loads, and metabolic load that a human subject would have produced during load carriage with and without the use of a robotic exoskeleton. This data will help the Army analyze the benefits of exoskeletons and develop injury predictions.

“By directly modeling the interaction between a human user and the exoskeleton, our simulator will help to identify potential injury mechanisms and issues before any large-scale deployment of the device – ultimately reducing injuries while saving the Army time and money,” stated Jorgen Pedersen, president and CEO for RE2.

RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics™ (OTCBB: EKSO), neuromusculoskeletal simulation leader, Dr. Scott Delp and Dr. Jennifer Hicks, faculty at Stanford University, and the Human Engineering Research Laboratories at the University of Pittsburgh to design and test the Biomechanical Exoskeleton Simulator System."


EksoZeroG and Artemis (Construction/Tool Usage):


Ekso Bionics has spent several years designing and perfecting a range of ergonomic tool arms which are used to weightlessly manoeuvre heavy tools. These arms rely on spring tension and innovative design to balance the weight of tools used in drilling, sanding, riveting and many other applications. The Ekso Bionics Zero G arms are designed to hold loads of up to 19kg and fully balance the weight thus allowing the user to freely, safely and accurately manoeuvre the load in any direction without injury or fatigue.

The ergonomic tool arms have a variety of mounting options to suit the application including portable gantry’s, carts, jib arms, and linear rail. These systems require very little maintenance, no expensive inputs like electricity or compressed air, and have already been successfully used in a variety of industries from aerospace and defence to automotive manufacturing.

  • -Payback of less than a year
    -ROI of 100%
    -Less than 30 min of operator training required to achieve competency
    -No expensive inputs such as electricity or air required
    -Very minimal maintenance
    -Modular design for flexibility
    -13 different mobile and fixed mounting options
    -4 different arm configurations

There are several mounting options fro the Zero G ergonomic tool arms from ground based trolleys, to gantry mounts, jib crane mounts, linear rail and bench top mounting.

The Zero G ergonomic tool arm is used extensively in the aerospace,construction, mining and ship building industries in a range of roles. The weight balancing aspect of the Equipois Zero G system allows workers to grind, drill, chip surfaces easily for long periods of time even if the surface is in an overhead orientation.

Current users of the Equipois Zero G system include Airbus, Boeing, General Electric, BHP Billiton, Gammon Construction, Lockheed Martin, Chrysler, Ford, Honda, Nissan, Toyota, Caterpillar, John Deere, Bradken and many more.


Ekso Artemis:

"RICHMOND, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an exoskeleton company, today announced that it has completed the development of a lightweight, flexible load carriage exoskeleton prototype named Artemis."

Ekso Bionics at a Glance:
-Founded in 2005 and headquartered in Richmond, CA 
-Industry leaders in healthcare, military, and industrial exoskeletons
-The Ekso Bionics Ekso GT™ is the first exoskeleton approved for stroke rehabiliation
-The current CEO is Thomas Looby
-Over 190 international patent cases (granted or pending)
-Originally Berkely Bionics of Univsity of California, Berkeley
-Headquartered in the historic Ford Motor Company Assembly Plant, the largest wartime production assembly plant to be built on the West Coast
Company Presentation:

*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
Do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested. There are no guarantees when buying or selling any security.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EKSO News: Current Report Filing (8-k) 06/21/2017 06:05:27 AM
EKSO News: Notice of Effectiveness (effect) 06/19/2017 06:03:03 AM
EKSO News: Ekso BionicsĀ® Announces Centers of Robotic Excellence Collaborating with Rehabilitation Facilities for Mobility Impaired 06/15/2017 08:00:00 AM
EKSO News: Securities Registration Statement (simplified Form) (s-3) 06/06/2017 10:45:10 AM
EKSO News: Ekso Bionics Develops Lightweight Flexible Exoskeleton Technology Expanding Technical & Intellectual Property Leadership 06/05/2017 08:00:00 AM
#2381  Sticky Note On Talos: [continued "top level support" for the Rhetorical 08/16/16 07:02:33 PM
#1234  Sticky Note $EKSO recent news/filings RECENT NEWS 02-03-16 1 MIL. GRANT mick 02/04/16 11:05:48 AM
#3503   do u mean 150 % back to berta 06/22/17 06:50:27 PM
#3502   Yes, my opinion is this needs to triple radly 06/22/17 06:06:38 PM
#3501   When it comes to rehab etc. This technology packerfan9 06/22/17 04:19:22 PM
#3500   Some of this was stated previously but it skepticone 06/22/17 04:02:07 PM
#3499   Wow, even this pump didn't budge it. golfblues 06/22/17 10:43:35 AM
#3498   Looking at the 52 week chart I am skepticone 06/22/17 08:55:04 AM
#3497   If you want to keep current on EKSO skepticone 06/22/17 08:14:38 AM
#3496 skepticone 06/22/17 08:09:55 AM
#3495   What I want to know is what the radly 06/21/17 07:37:55 PM
#3494   Great video! Excellent find skep! Bobby Marinov 06/21/17 05:42:35 PM
#3493 skepticone 06/21/17 01:51:54 PM
#3492   I would rather see pictures or videos of skepticone 06/21/17 08:03:57 AM
#3491   The XO's of Ekso are awfully quiet about Artemis Rhetorical 06/21/17 01:03:43 AM
#3490   OLD news, most likely some dilution along the way. berta 06/19/17 09:21:03 PM
#3489   Is there more dilution coming? Grayghost 06/19/17 08:35:10 PM
#3488   Doesn't look like it! skepticone 06/19/17 09:30:45 AM
#3487   The MicroCap Daily article will hopefully keep us Rhetorical 06/19/17 09:14:52 AM
#3486   nice post thanks TrueTrades 06/17/17 10:34:38 PM
#3485   the best and biggest thing I missed researching: Rhetorical 06/17/17 04:27:01 PM
#3484   Ekso Bionics Holdings, Inc.(NASDAQ:EKSO) Heats Up Rhetorical 06/17/17 02:00:37 PM
#3483   My favorite thing about EKSO is this: Rhetorical 06/16/17 09:54:21 AM
#3482   * * $EKSO Video Chart 06-15-17 * * ClayTrader 06/15/17 05:01:28 PM
#3481   The robotic device allows us to get patients packerfan9 06/15/17 04:42:02 PM
#3480   FOLLOW THIS BOARD!!! Artemis, Ekso's new product is Rhetorical 06/15/17 10:42:34 AM
#3479   This win-win news is REALLY important. "Centers of Rhetorical 06/15/17 10:26:33 AM
#3478   ^$ ::))) ~MulaGreen~ 06/15/17 09:42:52 AM
#3477   my pleasure.....$2.50-$3.00 let's goooooooooooooo EKSO stockdawg44 06/15/17 09:08:26 AM
#3476   Yo!!!Stockdawg44!!!Muchas Gracias for the PM yesterday. ^$ ~MulaGreen~ 06/15/17 09:06:59 AM
#3475   EKSO $2.50+ today...Let's go....... stockdawg44 06/15/17 09:02:06 AM
#3474   EKSO NEWS OUT Ekso Bionics® Announces Centers [SMART MONEY] 06/15/17 08:36:40 AM
#3472   Like I said in another post, I was skepticone 06/14/17 07:16:02 PM
#3471   thanks it is what it is I berta 06/14/17 07:08:58 PM
#3470   I am curious to know what Mr. Fitz-Gerald's skepticone 06/14/17 07:01:46 PM
#3469   Good luck to you Berta, wish you would skepticone 06/14/17 06:56:40 PM
#3468   During the other rallies the PPS crossed the skepticone 06/14/17 06:53:27 PM
#3467   GOOD ONE by the way YOU all berta 06/14/17 06:53:13 PM
#3466   Reference posts #3421 and #3436...On 4 June I skepticone 06/14/17 06:47:46 PM
#3465   * * $EKSO Video Chart 06-14-17 * * ClayTrader 06/14/17 04:21:41 PM
#3464   If I hadn't been quoted in a prior Rhetorical 06/14/17 04:17:49 PM
#3463   Really? OK, I expect this to be kpisme 06/14/17 02:10:45 PM
#3462   Yup rebounding nicely Tdash 06/14/17 01:52:51 PM
#3461   EKSO looking real good here..... stockdawg44 06/14/17 01:36:03 PM
#3460   looking good Tdash 06/14/17 12:57:24 PM
#3459   You guys see how influential this forum is? Bobby Marinov 06/14/17 10:53:00 AM
#3458   I just finished reading that article and was skepticone 06/14/17 08:27:33 AM
#3457   A bit of cautious optimism: mvan13 06/14/17 06:43:24 AM
#3456   I am out as my stop got triggered. abira 06/08/17 10:17:22 AM
#3455   Rhet...I realize that a prototype is beyond IP... skepticone 06/07/17 10:55:13 PM
#3454   I caught the very tale end of my radly 06/07/17 07:17:09 PM
#3453   They have "completed development" which is a statement Rhetorical 06/07/17 05:48:15 PM